Glaxo Licenses Tuberculosis Vaccine To Bill Gates Research Institute Read More
UK BROKER RATINGS SUMMARY: Berenberg Downgrades Unilever To Hold Read More
US Regulator Grants Priority Review Of Glaxo's Belantamab Mafodotin Read More
Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director Read More
UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight Read More
LONDON BRIEFING: AB Foods Reports Sales Rises Across Portfolio Read More
Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On Read More
UK BROKER RATINGS SUMMARY: Peel Hunt Cuts SIG After Profit Warning Read More
UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons Read More
UK Dividends Calendar - Next 7 Days Read More
GlaxoSmithKline Completes EUR955 Million Sale Of Travel Vaccines Read More
UK WINNERS & LOSERS SUMMARY: NMC Surges On Plan For Independent Review Read More
US FDA Rejects New Drug Application For ViiV Healthcare HIV Treatment Read More
GlaxoSmithKline Pleased With Benlysta Phase 3 Test Results Read More
UK BROKER RATINGS SUMMARY: Bank Of America Upgrades HSBC To Buy Read More
Glaxo's ViiV Healthcare Submits Application For Fostemsavir Approval Read More
TOP NEWS: Hikma Submits Response To Advair Application Deficiencies Read More
LONDON MARKET MIDDAY: China Threatens Retaliation Over Hong Kong Bill Read More
UK BROKER RATINGS SUMMARY: UBS High On Glaxo, Deutsche Down On Aviva Read More
UK BROKER RATINGS SUMMARY: Jefferies And JPMorgan Both Cut Tullow Oil Read More
